Orthopedics Today reported on a platelet-rich plasma (PRP) study presented at the Arthroscopy Association of North America Annual Meeting. “Matthew J. Kraeutler, MD, and colleagues randomly assigned 32 hips with early OA in 30 patients to receive treatment with either PRP or hyaluronic acid. Researchers collected WOMAC scores and assessed patient-reported outcomes and hip range of motion at baseline and at 6 weeks, 3 months and 6 months after injection,” according to the article. The study concluded that patients who had PRP vs. hyaluronic acid injections underwent total hip arthroplasty at a significantly lower rate. Full story.